LIGAND PHARMACEUTICALS INCORPORATED Noncontrolling Interest, Decrease from Deconsolidation
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Noncontrolling Interest, Decrease from Deconsolidation of $4.29 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-01.
Discontinued › Shareholders' Equity
us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation · last filed 2018-03-01
- LIGAND PHARMACEUTICALS INCORPORATED noncontrolling interest, decrease from deconsolidation for fiscal 2015 was $4.29M.
| Period end | Noncontrolling Interest, Decrease from Deconsolidation 12 month |
|---|---|
| 2015-12-31 | $4.29M 10-K · filed 2018-03-01 |